NEWS 5 NORTH AMERICA
Editor Richard Scott
richardscott@stepcomms.com
Technical Editor Chris Smith
chrissmith@stepcomms.com
Business Manager Chris Vincent
chrisvincent@stepcomms.com
Publication Administration Katy Cockle
katycockle@stepcomms.com
Design Aaron Batson
Publisher Geoff King
geoffking@stepcomms.com
Publishing Director Trevor Moon
trevormoon@stepcomms.com
In memory of Josh Taylor
To receive regular copies of this magazine, please apply in writing to The Circulation Dept, Step Communications Ltd
The secret to nighttime skin restoration
Ashland has announced the launch of Nightessence biofunctional: a natural extract from premium true lavender flowers using the patented and proprietary plant small RNA technology. This is a first of its kind biofunctional tailored to optimize skin’s nighttime needs and allows consumers to awaken with skin re-set for the day ahead. It helps restore skin overnight, so it looks rested, renewed and illuminated by morning. The Nightessence
showed a more rested skin with fewer dark circles. Nightessence biofunctional
biofunctional was clinically tested on a group of 36 Asian volunteers who worked a night shift or who stayed up very late. After a month, the volunteers
was eco-consciously designed from field-to-skin. The company’s Lavandula angustifolia premium lavender is grown sustainably, respecting nature in its cultivation and harvesting techniques on the mountain slopes in Provence, France, 140 kilometers from the Ashland biofunctional facility. It is extracted using green chemistry to offer a novel type of lavender essence to the cosmetic market.
Sanitizer and vaccine developments
Amyris is launching a hand sanitizer to help address the high demand triggered by COVID-19. Additionally, the company has completed initial testing of a leading vaccine adjuvant. Amyris is leveraging its
Download the Personal Care app and see the latest issue on PC, Android, Tablet and IOS devices
STEP COMMUNICATIONS
Published by: Step Communications Ltd Step House, North Farm Road, Tunbridge Wells, Kent TN2 3DR, UK
Tel: +44 (0)1892 779999 Fax: +44 (0)1892 616177
Email:
info@personalcaremagazine.com
Website:
www.personalcaremagazine.com
Printed by: CPI Colour
©Step Communications Ltd 2020
No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means: electronic, mechanical, photocopying, recording or otherwise without prior permission of the publisher
ISSN 2631–4894 May 2020 PERSONAL CARE NORTH AMERICA
existing capabilities to fast-track the availability of a safe and clean No Compromise Pipette Baby branded hand sanitizer that can be used by everyone. This product is focused on high performance cleaning while being healthy for your hands.
EDITOR’S COMMENT Coming to terms with a new normal
The word ‘unprecedented’ is being used a great deal at the moment, but for good reason. This is a new scenario for everyone and there are no benchmarks to go by. Very little is certain and the situation changes rapidly, but what has been clear is that much of what our industry creates is critical to improving the level of success in the fight against the virus. We have been closely following the personal care industry’s response
to the crisis and amid the gloom there have been many examples of innovation and selflessness, re-purposing labs to increase supply of vital sanitizers for front-line staff. This has been incredible to see. Some sectors of personal care will be harder hit than others and
there may be long-term changes. For regular updates and the latest industry developments, make sure you visit
www.personalcaremagazine.com and download our app.
Richard Scott, Editor
Amyris will not price its hand sanitizer at a premium, and plans to donate part of the supply to front-line health staffers and medical personnel. In partnership with the
Infectious Diseases Research Institute (IDRI), Amyris has completed initial testing of its fermentation-derived squalene as a vaccine adjuvant. The company is in active discussion with a leader in the pharmaceutical industry to target broad application of Amyris squalene in
'flu and potential COVID-19 vaccines. John Melo, president and
CEO of Amyris, commented: “We are committed to No Compromise products, formulations and ingredients. Our hand sanitizer is a great example of swiftly applying our market-leading squalane moisturizer to an immediate need. We expect to produce an estimated 30,000 units in the first weeks and to expand production quickly.”
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96
